APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drug

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Selected research

Market Structure

Global Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchVeterinary Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drug Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report provides an overview of the global Veterinary Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Veterinary Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Drug Segment by Company

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Drug Segment by Type

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Veterinary Drug Segment by Application

Pets

Cattle

Poultry

Swine

Others

Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Drug Industry Trends Table 2. Veterinary Drug Industry Drivers Table 3. Veterinary Drug Industry Opportunities and Challenges Table 4. Veterinary Drug Industry Restraints Table 5. Global Veterinary Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Drug Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Veterinary Drug Sales Market Share by Manufacturers Table 9. Global Veterinary Drug Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Drug Manufacturers, Product Type & Application Table 13. Global Veterinary Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-Infectives Table 17. Major Manufacturers of Anti-Inflammatory Table 18. Major Manufacturers of Parasiticides Table 19. Major Manufacturers of Analgesics Table 20. Major Manufacturers of Sedatives Table 21. Major Manufacturers of Others Table 22. Global Veterinary Drug Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 23. Global Veterinary Drug Sales by Type (2021-2026) & (M Units) Table 24. Global Veterinary Drug Sales by Type (2027-2032) & (M Units) Table 25. Global Veterinary Drug Sales Market Share by Type (2021-2026) Table 26. Global Veterinary Drug Sales Market Share by Type (2027-2032) Table 27. Global Veterinary Drug Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 28. Global Veterinary Drug Revenue by Type (2021-2026) & (M Units) Table 29. Global Veterinary Drug Revenue by Type (2027-2032) & (M Units) Table 30. Global Veterinary Drug Revenue Market Share by Type (2021-2026) Table 31. Global Veterinary Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Pets Table 33. Major Manufacturers of Cattle Table 34. Major Manufacturers of Poultry Table 35. Major Manufacturers of Swine Table 36. Major Manufacturers of Others Table 37. Global Veterinary Drug Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Veterinary Drug Sales by Application (2021-2026) & (M Units) Table 39. Global Veterinary Drug Sales by Application (2027-2032) & (M Units) Table 40. Global Veterinary Drug Sales Market Share by Application (2021-2026) Table 41. Global Veterinary Drug Sales Market Share by Application (2027-2032) Table 42. Global Veterinary Drug Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 43. Global Veterinary Drug Revenue by Application (2021-2026) & (M Units) Table 44. Global Veterinary Drug Revenue by Application (2027-2032) & (M Units) Table 45. Global Veterinary Drug Revenue Market Share by Application (2021-2026) Table 46. Global Veterinary Drug Revenue Market Share by Application (2027-2032) Table 47. Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 48. Global Veterinary Drug Sales by Region (2021-2026) & (M Units) Table 49. Global Veterinary Drug Sales Market Share by Region (2021-2026) Table 50. Global Veterinary Drug Sales Forecasted by Region (2027-2032) & (M Units) Table 51. Global Veterinary Drug Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. North America Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 54. North America Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 55. Europe Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Europe Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 57. Europe Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 58. Asia Pacific Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. Asia Pacific Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 60. Asia Pacific Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 61. South America, Middle East and Africa Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 62. South America, Middle East and Africa Veterinary Drug Sales by Country (2021-2026) & (M Units) Table 63. South America, Middle East and Africa Veterinary Drug Sales by Country (2027-2032) & (M Units) Table 64. Global Veterinary Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Veterinary Drug Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Veterinary Drug Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Veterinary Drug Revenue Market Share by Region (2021-2026) Table 68. Global Veterinary Drug Revenue Market Share by Region (2027-2032) Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zoetis Veterinary Drug Product Portfolio Table 73. Zoetis Recent Development Table 74. Elanco Company Information Table 75. Elanco Business Overview Table 76. Elanco Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Elanco Veterinary Drug Product Portfolio Table 78. Elanco Recent Development Table 79. Boehringer Ingelheim Company Information Table 80. Boehringer Ingelheim Business Overview Table 81. Boehringer Ingelheim Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Boehringer Ingelheim Veterinary Drug Product Portfolio Table 83. Boehringer Ingelheim Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merck Veterinary Drug Product Portfolio Table 88. Merck Recent Development Table 89. Virbac Company Information Table 90. Virbac Business Overview Table 91. Virbac Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Virbac Veterinary Drug Product Portfolio Table 93. Virbac Recent Development Table 94. Ceva Company Information Table 95. Ceva Business Overview Table 96. Ceva Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Ceva Veterinary Drug Product Portfolio Table 98. Ceva Recent Development Table 99. Vetoquinol Company Information Table 100. Vetoquinol Business Overview Table 101. Vetoquinol Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Vetoquinol Veterinary Drug Product Portfolio Table 103. Vetoquinol Recent Development Table 104. Dechra Company Information Table 105. Dechra Business Overview Table 106. Dechra Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dechra Veterinary Drug Product Portfolio Table 108. Dechra Recent Development Table 109. Norbrook Company Information Table 110. Norbrook Business Overview Table 111. Norbrook Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Norbrook Veterinary Drug Product Portfolio Table 113. Norbrook Recent Development Table 114. Phibro Company Information Table 115. Phibro Business Overview Table 116. Phibro Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Phibro Veterinary Drug Product Portfolio Table 118. Phibro Recent Development Table 119. Huvepharma Company Information Table 120. Huvepharma Business Overview Table 121. Huvepharma Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Huvepharma Veterinary Drug Product Portfolio Table 123. Huvepharma Recent Development Table 124. Hipra Company Information Table 125. Hipra Business Overview Table 126. Hipra Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Hipra Veterinary Drug Product Portfolio Table 128. Hipra Recent Development Table 129. Ouro Fino Saude Company Information Table 130. Ouro Fino Saude Business Overview Table 131. Ouro Fino Saude Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Ouro Fino Saude Veterinary Drug Product Portfolio Table 133. Ouro Fino Saude Recent Development Table 134. CAHIC Company Information Table 135. CAHIC Business Overview Table 136. CAHIC Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. CAHIC Veterinary Drug Product Portfolio Table 138. CAHIC Recent Development Table 139. Orion Company Information Table 140. Orion Business Overview Table 141. Orion Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Orion Veterinary Drug Product Portfolio Table 143. Orion Recent Development Table 144. Ringpu Biology Company Information Table 145. Ringpu Biology Business Overview Table 146. Ringpu Biology Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Ringpu Biology Veterinary Drug Product Portfolio Table 148. Ringpu Biology Recent Development Table 149. Nippon Zenyaku Kogyo Company Information Table 150. Nippon Zenyaku Kogyo Business Overview Table 151. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio Table 153. Nippon Zenyaku Kogyo Recent Development Table 154. Farmavet-Pasteur Company Information Table 155. Farmavet-Pasteur Business Overview Table 156. Farmavet-Pasteur Veterinary Drug Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Farmavet-Pasteur Veterinary Drug Product Portfolio Table 158. Farmavet-Pasteur Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Veterinary Drug Distributors List Table 162. Veterinary Drug Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Veterinary Drug Product Image Figure 2. Global Veterinary Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Drug Sales (2021-2032) & (M Units) Figure 5. Global Veterinary Drug Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-Infectives Image Figure 9. Anti-Inflammatory Image Figure 10. Parasiticides Image Figure 11. Analgesics Image Figure 12. Sedatives Image Figure 13. Others Image Figure 14. Global Veterinary Drug Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Veterinary Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Drug Sales Market Share by Type (2021-2032) Figure 17. Global Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 18. Global Veterinary Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Drug Revenue Market Share by Type (2021-2032) Figure 20. Pets Image Figure 21. Cattle Image Figure 22. Poultry Image Figure 23. Swine Image Figure 24. Others Image Figure 25. Global Veterinary Drug Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Veterinary Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Veterinary Drug Sales Market Share by Application (2021-2032) Figure 28. Global Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 29. Global Veterinary Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Veterinary Drug Revenue Market Share by Application (2021-2032) Figure 31. North America Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 32. North America Veterinary Drug Sales Market Share by Country (2021-2032) Figure 33. U.S. Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Canada Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Mexico Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Europe Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Europe Veterinary Drug Sales Market Share by Country (2021-2032) Figure 38. Germany Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 39. France Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 40. U.K. Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Italy Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Netherlands Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Asia Pacific Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Asia Pacific Veterinary Drug Sales Market Share by Country (2021-2032) Figure 45. China Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Japan Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Korea Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Southeast Asia Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 49. India Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Australia Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South America, Middle East and Africa Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 52. South America, Middle East and Africa Veterinary Drug Sales Market Share by Country (2021-2032) Figure 53. Brazil Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 54. South Africa Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Saudi Arabia Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Turkey Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Argentina Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 58. UAE Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 59. Egypt Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 60. Chile Veterinary Drug Sales and Growth Rate (2021-2032) & (M Units) Figure 61. Global Veterinary Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Veterinary Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 64. North America Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 66. Europe Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Veterinary Drug Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Veterinary Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
Applications
  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others
Companies covered
  • Zoetis
  • Elanco
  • Boehringer Ingelheim
  • Merck
  • Virbac
  • Ceva
  • Vetoquinol
  • Dechra
  • Norbrook
  • Phibro
  • Huvepharma
  • Hipra
  • Ouro Fino Saude
  • CAHIC
  • Orion
  • Ringpu Biology
  • Nippon Zenyaku Kogyo
  • Farmavet-Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Drug Market Dynamics
  1. 2.1 Veterinary Drug Industry Trends
  2. 2.2 Veterinary Drug Industry Drivers
  3. 2.3 Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Veterinary Drug Industry Restraints
3 Veterinary Drug Market by Manufacturers
  1. 3.1 Global Veterinary Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Drug Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Drug Tier 1, Tier 2, and Tier 3
4 Veterinary Drug Market by Type
  1. 4.1 Veterinary Drug Type Introduction
  2. 4.1.1 Anti-Infectives
  3. 4.1.2 Anti-Inflammatory
  4. 4.1.3 Parasiticides
  5. 4.1.4 Analgesics
  6. 4.1.5 Sedatives
  7. 4.1.6 Others
  8. 4.2 Global Veterinary Drug Sales by Type
  9. 4.2.1 Global Veterinary Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Veterinary Drug Sales by Type (2021-2032)
  11. 4.2.3 Global Veterinary Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global Veterinary Drug Revenue by Type
  13. 4.3.1 Global Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Veterinary Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global Veterinary Drug Revenue Market Share by Type (2021-2032)
5 Veterinary Drug Market by Application
  1. 5.1 Veterinary Drug Application Introduction
  2. 5.1.1 Pets
  3. 5.1.2 Cattle
  4. 5.1.3 Poultry
  5. 5.1.4 Swine
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Drug Sales by Application
  8. 5.2.1 Global Veterinary Drug Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Veterinary Drug Sales by Application (2021-2032)
  10. 5.2.3 Global Veterinary Drug Sales Market Share by Application (2021-2032)
  11. 5.3 Global Veterinary Drug Revenue by Application
  12. 5.3.1 Global Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Veterinary Drug Revenue by Application (2021-2032)
  14. 5.3.3 Global Veterinary Drug Revenue Market Share by Application (2021-2032)
6 Global Veterinary Drug Sales by Region
  1. 6.1 Global Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Drug Revenue by Region
  1. 7.1 Global Veterinary Drug Revenue by Region
  2. 7.1.1 Global Veterinary Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Drug Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Drug Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Drug Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Elanco
  8. 8.2.1 Elanco Company Information
  9. 8.2.2 Elanco Business Overview
  10. 8.2.3 Elanco Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Elanco Veterinary Drug Product Portfolio
  12. 8.2.5 Elanco Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Veterinary Drug Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Virbac
  26. 8.5.1 Virbac Company Information
  27. 8.5.2 Virbac Business Overview
  28. 8.5.3 Virbac Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Virbac Veterinary Drug Product Portfolio
  30. 8.5.5 Virbac Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Veterinary Drug Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Veterinary Drug Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Dechra
  44. 8.8.1 Dechra Company Information
  45. 8.8.2 Dechra Business Overview
  46. 8.8.3 Dechra Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dechra Veterinary Drug Product Portfolio
  48. 8.8.5 Dechra Recent Developments
  49. 8.9 Norbrook
  50. 8.9.1 Norbrook Company Information
  51. 8.9.2 Norbrook Business Overview
  52. 8.9.3 Norbrook Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Veterinary Drug Product Portfolio
  54. 8.9.5 Norbrook Recent Developments
  55. 8.10 Phibro
  56. 8.10.1 Phibro Company Information
  57. 8.10.2 Phibro Business Overview
  58. 8.10.3 Phibro Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Phibro Veterinary Drug Product Portfolio
  60. 8.10.5 Phibro Recent Developments
  61. 8.11 Huvepharma
  62. 8.11.1 Huvepharma Company Information
  63. 8.11.2 Huvepharma Business Overview
  64. 8.11.3 Huvepharma Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huvepharma Veterinary Drug Product Portfolio
  66. 8.11.5 Huvepharma Recent Developments
  67. 8.12 Hipra
  68. 8.12.1 Hipra Company Information
  69. 8.12.2 Hipra Business Overview
  70. 8.12.3 Hipra Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hipra Veterinary Drug Product Portfolio
  72. 8.12.5 Hipra Recent Developments
  73. 8.13 Ouro Fino Saude
  74. 8.13.1 Ouro Fino Saude Company Information
  75. 8.13.2 Ouro Fino Saude Business Overview
  76. 8.13.3 Ouro Fino Saude Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
  78. 8.13.5 Ouro Fino Saude Recent Developments
  79. 8.14 CAHIC
  80. 8.14.1 CAHIC Company Information
  81. 8.14.2 CAHIC Business Overview
  82. 8.14.3 CAHIC Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CAHIC Veterinary Drug Product Portfolio
  84. 8.14.5 CAHIC Recent Developments
  85. 8.15 Orion
  86. 8.15.1 Orion Company Information
  87. 8.15.2 Orion Business Overview
  88. 8.15.3 Orion Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Orion Veterinary Drug Product Portfolio
  90. 8.15.5 Orion Recent Developments
  91. 8.16 Ringpu Biology
  92. 8.16.1 Ringpu Biology Company Information
  93. 8.16.2 Ringpu Biology Business Overview
  94. 8.16.3 Ringpu Biology Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Ringpu Biology Veterinary Drug Product Portfolio
  96. 8.16.5 Ringpu Biology Recent Developments
  97. 8.17 Nippon Zenyaku Kogyo
  98. 8.17.1 Nippon Zenyaku Kogyo Company Information
  99. 8.17.2 Nippon Zenyaku Kogyo Business Overview
  100. 8.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
  102. 8.17.5 Nippon Zenyaku Kogyo Recent Developments
  103. 8.18 Farmavet-Pasteur
  104. 8.18.1 Farmavet-Pasteur Company Information
  105. 8.18.2 Farmavet-Pasteur Business Overview
  106. 8.18.3 Farmavet-Pasteur Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
  108. 8.18.5 Farmavet-Pasteur Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Drug Value Chain Analysis
  2. 9.1.1 Veterinary Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Drug Production Mode & Process
  6. 9.2 Veterinary Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Drug Distributors
  9. 9.2.3 Veterinary Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst